NKO Beat
Natural health product licensed in Canada
- Other names
- OCEANO3 Beat
- Licence holder
- Biodroga Nutraceuticals Inc.
- NPN or DIN-HM
- 80060414
- Status
- Active licence
- Licence date
- 29 April 2015
- Revision date
- 17 March 2023
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de krill Source : Euphausia superba - en entier Potency : 210 milligramme Phospholipids | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 150 milligramme Omega-3 Fatty Acids | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 0.5 milligramme Esterified Astaxanthin | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 45 milligramme Docosahexaenoic acid | 500 milligramme | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 75 milligramme Eicosapentaenoic acid | Not specified | Not calculated |
| Vitamine B12 Source : Méthylcobalamine | 0.5 milligramme | 1,000 µg |
| Folate Source : Acide folique | 0.2 milligramme | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Rhodobacter sphaeroides - Cellule entière pour biosynthèse | 50 milligramme | Not calculated |
Non-medicinal ingredients
Vanilline, Poudre de caroube, Monostéarate de glycéryle, Eau purifiée, Lycopène, Cire jaune, Lécithine, Gélatine, Sorbitol, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of EPA and DHA for the maintenance of good health. A factor in the maintenance of good health. Helps to form red blood cells. Helps to maintain and/or support cardiovascular health. Helps to prevent vitamin B12 deficiency. Helps to prevent folate deficiency. An antioxidant for the maintenance of good health. Helps to reduce the levels of LDL cholesterol in conjunction with conventional statin therapy. Helps to increase the levels of HDL cholesterol in conjunction with conventional statin therapy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80060414
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging